Feedback / Questions
Wegovy (semaglutide injection once weekly) - Novo Nordisk
Wegovy: Newly added patent in Orange Book
(Orange Book)
-
Mar 6, 2026 -
Expiry on Oct 10, 2038
Patent
•
Metabolic Disorders • Metabolic Dysfunction-Associated Steatohepatitis • Metabolic Dysfunction-Associated Steatotic Liver Disease
https://www.accessdata.fda.gov/scripts/cder/ob/search_patent.cfm?listed=new
Mar 6, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious